Treatment of Atherosclerotic Renovascular Disease

Author(s): Vanessa dos Santos Silva, Roberto Jorge da Silva Franco, Luis Cuadrado Martin

Journal Name: Current Hypertension Reviews

Volume 4 , Issue 2 , 2008

Become EABM
Become Reviewer


Treatment of atherosclerotic renovascular disease is controversial and revascularization is not a beneficial approach to all patients. Conditions as progressive deterioration of renal function, refractory hypertension or accelerated cardiovascular disease, especially recurrent pulmonary edema, could profit from renal angioplasty with stent placement. Surgical revascularization is a good option for patients who will need concomitant surgical corrections of abdominal aortic lesions. Treatment of all other patients must be individualized. Medical therapy is indicated for all patients with atherosclerotic renovascular disease. Observational studies pointed out to the beneficial effect of controlling blood pressure ( < 130/80 mm Hg), glucose and lipids profile, lifestyle modifications, specific use of platelet antiaggregant therapy, Angiotensin Conversion Enzyme Inhibitors (ACEI) and statins. All others cardiovascular risk factors must be controlled. The evaluation and management of other systemic atherosclerotic vascular lesions is important, especially coronary, carotid and abdominal aortic. This paper presents a review of evidences to rationale the atherosclerotic renovascular disease treatment.

Keywords: Renovascular, atherosclerosis, renal angioplasty, medical therapy, renal artery stenosis, treatment

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2008
Page: [114 - 120]
Pages: 7
DOI: 10.2174/157340208784245875
Price: $65

Article Metrics

PDF: 3